AstraZeneca: Clinical Trials & Research Profile
Biopharma Industry (Cambridge, UK / Wilmington, DE) · Primary Focus: Oncology and Hematology
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (Cambridge, UK / Wilmington, DE) |
| Primary Therapeutic Area | Oncology and Hematology |
| Active Phase II & III Studies | 300 active (134 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 534 (330 with California sites) |
| Completed vs Early-Stopped Studies | 175 completed / 59 stopped (11.1% stop rate) |
| Median Closed Enrollment | 181 participants |
| FDA Drugs@FDA Original Approvals | 81 all-time (21 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 0.9% named hospital slots |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for AstraZeneca across sibling Meru public-data platforms.
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk